Rutherford A V, Willingham M C
Ultrastructural Cytochemistry Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
J Histochem Cytochem. 1993 Oct;41(10):1573-7. doi: 10.1177/41.10.7902372.
We localized the chemotherapeutic drug daunomycin inside cultured cells by taking advantage of its inherent fluorescence. Multidrug-resistant cultured cells, in which the accumulation of daunomycin can be reversibly controlled with verapamil to block the multidrug transporter, were incubated in daunomycin and verapamil and the accumulated daunomycin was visualized with epifluorescence optics. After fixation under a variety of different conditions to make cells permeable to diaminobenzidine (DAB), the internal daunomycin was illuminated under the fluorescence microscope in the presence of DAB. Photooxidation of DAB in sites of fluorescing daunomycin (photoconversion) resulted in intracellular deposition of oxidized DAB product. These sites were then visualized by transmission electron microscopy. In cells in which the multidrug transporter was inhibited by verapamil, daunomycin was localized in the nucleus of cells by mild fixation conditions such as formaldehyde. Increasing amounts of glutaraldehyde in the fixative caused apparent quenching of the nuclear fluorescence but still allowed fluorescence to occur in other cell organelles, which were then well preserved. Daunomycin was found in the nuclear envelope, the endoplasmic reticulum, and in lysosomes in cells in which the multidrug transporter was inhibited. Lysosomal accumulation has been previously described and was expected because of the known accumulation of positively charged molecules in organelles with low pH. However, the accumulation of daunomycin in the nuclear envelope and endoplasmic reticulum has not been previously observed. These results clearly demonstrate the utility of fluorescence photoconversion methodology for the high-resolution ultrastructural localization of fluorescent materials.
我们利用化疗药物柔红霉素固有的荧光特性,将其定位在培养细胞内。在多药耐药的培养细胞中,柔红霉素的积累可以通过维拉帕米可逆地控制,以阻断多药转运蛋白。将这些细胞置于柔红霉素和维拉帕米中孵育,然后用落射荧光光学显微镜观察积累的柔红霉素。在多种不同条件下固定细胞,使其对二氨基联苯胺(DAB)具有通透性,然后在荧光显微镜下,在DAB存在的情况下照射细胞内的柔红霉素。在发出荧光的柔红霉素部位(光转化),DAB发生光氧化,导致氧化DAB产物在细胞内沉积。然后通过透射电子显微镜观察这些部位。在维拉帕米抑制多药转运蛋白的细胞中,通过甲醛等温和固定条件,柔红霉素定位于细胞核。固定剂中戊二醛含量增加会导致细胞核荧光明显淬灭,但仍允许其他细胞器发出荧光,这些细胞器随后得到良好保存。在多药转运蛋白受到抑制的细胞中,在核膜、内质网和溶酶体中发现了柔红霉素。溶酶体积累此前已有描述,鉴于已知带正电荷的分子会在低pH值的细胞器中积累,这是意料之中的。然而,此前尚未观察到柔红霉素在核膜和内质网中的积累。这些结果清楚地证明了荧光光转化方法在荧光材料高分辨率超微结构定位方面的实用性。